DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initation factor 5A, transgenic plants and a method for controlling senescene and programmed cell death in plants
申请人:Senesco, Inc.
公开号:EP1881072A1
公开(公告)日:2008-01-23
Regulation of expression of programmed cell death, including senescence, in plants is achieved by integration of a gene or gene fragment encoding senescence-induced deoxyhypusine synthase, senescence-induced elF-5A or both into the plant genome in antisense orientation. Plant genes encoding senescence-induced deoxyhypusine synthase and senescence-induced elF-5A are identified and the nucleotide sequences of each, alone and in combination are used to modify senescence in transgenic plants.
Blagg, Julian; Davies, Stephen G.; Holman, Nicholas J., Journal of the Chemical Society. Perkin transactions I, 1986, p. 1581 - 1590
作者:Blagg, Julian、Davies, Stephen G.、Holman, Nicholas J.、Laughton, Charles A.、Mobbs, Bryan E.
DOI:——
日期:——
Blagg, Julian; Davies, Stephen G.; Holman, Nicholas J., Journal of the Chemical Society. Perkin transactions I
作者:Blagg, Julian、Davies, Stephen G.、Holman, Nicholas J.、Laughton, Charles A.、Mobbs, Bryan E.
DOI:——
日期:——
BLAGG J.; DAVIES S. G.; HOLMAN N. J.; LAUGHTON CH. A.; MOBBS B. E., J. CHEM. SOC. PERKIN TRANS.,(1986) N 9, 1581-1589
作者:BLAGG J.、 DAVIES S. G.、 HOLMAN N. J.、 LAUGHTON CH. A.、 MOBBS B. E.
DOI:——
日期:——
[EN] TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS<br/>[FR] DÉRIVÉS DE TÉTRAHYDRONAPHTALÈNE ET DE TÉTRAHYDROISOQUINOLÉINE EN TANT QU'AGENTS DE DÉGRADATION DES RÉCEPTEURS DES ŒSTROGÈNES
申请人:ARVINAS INC
公开号:WO2018102725A1
公开(公告)日:2018-06-07
The present disclosure relates to bifunctional compounds, which find utility as modulators of estrogen receptor (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end at least one of a Von Hippel-Lindau ligand, a cereblon ligand, Inhibitors of Apoptosis Proteins ligand, mouse double-minute homolog 2 ligand, or a combination thereof, which binds to the respective E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.